Entrada Therapeutics Inc Cash Flow Quality Index
Entrada Therapeutics Inc cash flow quality index. Entrada Therapeutics Inc (TRDA) has a Cash Flow Quality Index of -27.94x as of December 2024. Operating cash flow of $-31.61 Million is below net income of $1.13 Million, suggesting accrual-heavy earnings not yet converted to cash. See TRDA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Entrada Therapeutics Inc (2024–2024)
Cash flow quality index of Entrada Therapeutics Inc from 2024 to 2024. Historical Cash Flow Quality Index for Entrada Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore TRDA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Entrada Therapeutics Inc Cash Flow Quality Index by Year (2024–2024)
Entrada Therapeutics Inc cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for Entrada Therapeutics Inc. For the full cash flow conversion analysis, see TRDA cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.63x | $-41.56 Million | $65.63 Million | — |